NPPA fixes price of 22 drug formulations
While NPPA has fixed retail prices of 20 formulations, it has also capped the ceiling prices of two formulations, a notification…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Cipla receives final approval for Generic Isuprel
The drug is indicated for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy
Lupin launches generic Tobramycin Inhalation Solution USP in US
Tobramycin Inhalation Solution USP will treat cystic fibrosis patients with P. aeruginosa
Bayer to acquire stake in Monsanto India
The deal resulted in Bayer group indirectly acquiring 72.14 per cent stake in Monsanto India
Johnson & Johnson announces progress toward health for humanity goals
Annual health for humanity report discloses progress on global commitments and highlights key achievements toward eradicating and…
Schreiner MediPharm and Schreiner ProTech wins FINAT Awards
For nearly two decades, Schreiner Group has been among the annual award winners of the FINAT Label Competition
OGT expands custom NGS cancer panel content
Researchers can select content from a wide range of available NGS panel content available for solid tumours
Sun Pharma receives EIR for Halol facility
Warning letter issued in December 2015 have been addressed
AstraZeneca, Eli Lilly scrap Alzheimer’s treatment trial
The two firms had announced a partnership to develop a new drug aimed at combatting Alzheimer's in 2014
Suven Life Sciences gets product patents from China, US
Patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative…
CPhI & P-MEC India 2018 move to Indian capital
The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences
Oviya MedSafe to organise IndUS Drug Safety – one day workshop in Mumbai
The workshop will be open to pharma companies, with preference to representatives from Pharmacovigilance / Regulatory Affairs /…
Alembic Pharma gets USFDA approval for Bupropion Hydrochloride tablets
The drug approval is for strengths of 75 mg and 100 mg and is used to treat major depressive disorder
OPPI’s summit discusses on importance of quality standards for pharma industry
Pharma companies, government bodies, patient activists and healthcare practitioners gather to discuss how quality can become a key…
Cipla, Unitaid ink pact to cut price of HIV drug Geneva
The combination therapy is a once-daily pill that protects in three ways against TB
Cipla partners with Eli Lilly & Company to market diabetes drug BASAGLAR
BASAGLAR is a once-daily insulin glargine therapy for the treatment of patients with type 1 & 2 diabetes above two years of…
Aurobindo Pharma gets US FDA nod for heartburn drug
Omeprazole tablets are indicated for the treatment of frequent heartburn
DRL expects to launch generic Copaxone in H1 FY20 in US
Copaxone is a multi-billion dollar drug and a prescription medicine used for the treatment of people with relapsing forms of…
ZIM Laboratories eyes regulated markets
The company will get listed on the BSE on June 8, 2018
China approves first home made anti-HIV drug
The drug can block the fusion of the virus and host cell membranes, interrupting the HIV life cycle in its earliest stage